Adrenal insufficiency in septic shock

M Hatherill, S M Tibby, T Hilliard, C Turner, I A Murdoch, M Hatherill, S M Tibby, T Hilliard, C Turner, I A Murdoch

Abstract

Background: Functional adrenal insufficiency has been documented in critically ill adults.

Objective: To document the incidence of adrenal insufficiency in children with septic shock, and to evaluate its effect on catecholamine requirements, duration of intensive care, and mortality.

Setting: Sixteen-bed paediatric intensive care unit in a university hospital.

Methods: Thirty three children with septic shock were enrolled. Adrenal function was assessed by the maximum cortisol response after synthetic adrenocorticotropin stimulation (short Synacthen test). Insufficiency was defined as a post-Synacthen cortisol increment < 200 nmol/l.

Results: Overall mortality was 33%. The incidence of adrenal insufficiency was 52% and children with adrenal insufficiency were significantly older and tended to have higher paediatric risk of mortality scores. They also required higher dose vasopressors for haemodynamic stability. In the survivor group, those with adrenal insufficiency needed a longer period of inotropic support than those with normal function (median, 3 v 2 days), but there was no significant difference in duration of ventilation (median, 4 days for each group) or length of stay (median, 5 v 4 days). Mortality was not significantly greater in children with adrenal insufficiency than in those with adequate adrenal function (6 of 17 v 5 of 16, respectively).

Conclusion: Adrenal insufficiency is common in children with septic shock. It is associated with an increased vasopressor requirement and duration of shock.

References

    1. Crit Care Med. 1995 Aug;23(8):1430-9
    1. Intensive Care Med. 1995 Mar;21(3):204-10
    1. Intensive Care Med. 1995 Jan;21(1):57-62
    1. Intensive Care Med. 1996 Jul;22(7):707-10
    1. Intensive Care Med. 1996 Sep;22(9):894-9
    1. Intensive Care Med. 1997 Sep;23(9):987-91
    1. Crit Care Med. 1998 Apr;26(4):645-50
    1. Ann Surg. 1976 Sep;184(3):333-41
    1. Crit Care Med. 1983 Jan;11(1):1-3
    1. Arch Surg. 1984 Feb;119(2):145-50
    1. Am J Med. 1985 Dec;79(6):679-84
    1. J Pediatr. 1987 Sep;111(3):324-8
    1. N Engl J Med. 1987 Sep 10;317(11):653-8
    1. Crit Care Med. 1988 Nov;16(11):1110-6
    1. Endocrinology. 1991 Jan;128(1):623-9
    1. Scand J Infect Dis. 1990;22(6):755-6
    1. Lancet. 1991 Mar 9;337(8741):582-3
    1. Arch Surg. 1993 Jun;128(6):673-6
    1. J Pediatr. 1993 Oct;123(4):497-508
    1. Intensive Care Med. 1994;20(2):138-41
    1. J Clin Endocrinol Metab. 1994 Oct;79(4):923-31
    1. Intensive Care Med. 1994 Aug;20(7):489-95
    1. Intensive Care Med. 1994 Aug;20(7):522-8
    1. Am J Med. 1995 Mar;98(3):266-71
    1. New Horiz. 1995 Feb;3(1):2-32
    1. BMJ. 1995 May 13;310(6989):1253-4
    1. Intensive Care Med. 1995 Jun;21(6):515-21

Source: PubMed

3
Tilaa